日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Enhancing CAR- and TCR-mediated targeting of cancer via an immune synapse-stabilizing receptor

通过免疫突触稳定受体增强CAR和TCR介导的癌症靶向治疗

Chiou-Tsun Tsai,Jorge Ibanez-Vega,Pan Yin,Robert Teis,Norihiro Watanabe,Tadahiro Honda,Mikhail Valkov,Peter J Chockley,Lourdes Asenath Jimenez Madrigal,Giedre Krenciute,Maksim Mamonkin

International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML

急性髓系白血病CAR-T细胞临床试验的开展和报告国际共识指南

Naik, Swati; Aplenc, Richard; Baumeister, Susanne H C; Becilli, Marco; Bhagwat, Anand S; Bonifant, Challice L; Budde, Lihua E; Chien, Christopher D; Curran, Kevin J; Daniyan, Anthony F; Dreyzin, Alexandra; Gardner, Rebecca A; Ghorashian, Sara; Gottschalk, Stephen; Hill, LaQuisa C; Kohler, M Eric; Lamble, Adam; Locatelli, Franco; Mamonkin, Maksim; Omer, Bilal; Park, Jae H; Quintarelli, Concetta; Rambaldi, Benedetta; Richards, Rebecca M; Sallman, David A; Sauer, Tim; Shah, Nirali N; Subklewe, Marion; Summers, Corinne; Tasian, Sarah K; Taylor, Naomi; Tettamanti, Sarah; Verneris, Michael R; Velasquez, M Paulina; Gill, Saar I

Anti-viral CD8 central memory veto cells as a new platform for CAR T cell therapy

抗病毒CD8中央记忆抑制细胞作为CAR-T细胞疗法的新平台

Liu, Wei-Hsin; Globerson Levin, Anat; Lask, Assaf; Horn, Galit; Waks, Tova; Nathansohn Levi, Bar; Milman Krentsis, Irit; Shoshan, Einav; Su, Xiaohua; Mamonkin, Maksim; Champlin, Richard E; Reisner, Yair; Bachar Lustig, Esther

Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia

靶向IDH2R140Q和其他新抗原治疗急性髓系白血病

Leung, Wingchi K; Torres Chavez, Alejandro G; French-Kim, Matthew; Shafer, Paul; Mamonkin, Maksim; Hill, LaQuisa C; Kuvalekar, Manik; Velazquez, Yovana; Watanabe, Ayumi; Watanabe, Norihiro; Hoyos, Valentina; Lulla, Premal; Leen, Ann M

Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas

未经编辑的自体CD5.CAR T细胞治疗复发/难治性成熟T细胞淋巴瘤的抗肿瘤疗效和安全性

Hill, LaQuisa C; Rouce, Rayne H; Wu, Mengfen J; Wang, Tao; Ma, Royce; Zhang, Huimin; Mehta, Birju; Lapteva, Natalia; Mei, Zhuyong; Smith, Tyler S; Yang, Lina; Srinivasan, Madhuwanti; Burkhardt, Phillip M; Ramos, Carlos A; Lulla, Premal; Arredondo, Martha; Grilley, Bambi; Heslop, Helen E; Brenner, Malcolm K; Mamonkin, Maksim

Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity

嵌合抗原受体诱导的抗原丢失可保护CD5.CART细胞免受同源细胞杀伤,同时不影响其靶向细胞毒性。

Royce Ma ,Mae Woods ,Phillip Burkhardt ,Noah Crooks ,Dayenne G van Leeuwen ,Daniil Shmidt ,Jacob Couturier ,Alexandre Chaumette ,Divya Popat ,LaQuisa C Hill ,Rayne H Rouce ,Sachin Thakkar ,Aaron F Orozco ,Alexandre F Carisey ,Malcolm K Brenner ,Maksim Mamonkin

Human platelet lysate enhances in vivo activity of CAR-Vδ2 T cells by reducing cellular senescence and apoptosis

人血小板裂解物通过减少细胞衰老和凋亡增强 CAR-Vδ2 T 细胞的体内活性

Feiyan Mo, Chiou-Tsun Tsai, Rong Zheng, Chonghui Cheng, Helen E Heslop, Malcolm K Brenner, Maksim Mamonkin, Norihiro Watanabe

Engineering T cells to suppress acute GVHD and leukemia relapse after allogeneic hematopoietic stem cell transplantation

基因工程改造T细胞以抑制同种异体造血干细胞移植后的急性移植物抗宿主病和白血病复发

Feiyan Mo,Norihiro Watanabe,Kayleigh I Omdahl,Phillip M Burkhardt,Xiaoyun Ding,Eiko Hayase,Angela Panoskaltsis-Mortari,Robert R Jenq,Helen E Heslop,Leslie S Kean,Malcolm K Brenner,Victor Tkachev,Maksim Mamonkin

Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies

CD7 未编辑 CD7 CAR T 细胞治疗 T 细胞恶性肿瘤的可行性和临床前疗效

Norihiro Watanabe ,Feiyan Mo ,Rong Zheng ,Royce Ma ,Vanesa C Bray ,Dayenne G van Leeuwen ,Juntima Sritabal-Ramirez ,Hongxiang Hu ,Sha Wang ,Birju Mehta ,Madhuwanti Srinivasan ,Lauren D Scherer ,Huimin Zhang ,Sachin G Thakkar ,LaQuisa C Hill ,Helen E Heslop ,Chonghui Cheng ,Malcolm K Brenner ,Maksim Mamonkin

Apoptosis of Hematopoietic Stem Cells Contributes to Bone Marrow Suppression Following Chimeric Antigen Receptor T Cell Therapy

造血干细胞凋亡是嵌合抗原受体T细胞疗法后骨髓抑制的原因之一。

Read, Jay A; Rouce, Rayne H; Mo, Feiyan; Mamonkin, Maksim; King, Katherine Y